Alexis Sauer-Budge,
Biotechnology Managing Scientist, Exponent, Inc.
Dr. Sauer-Budge received her B.S./M.S. in Chemistry from Stanford University and her Ph.D. in Biophysics from Harvard University. While at Harvard, she worked on developing methods for studying and controlling the passage of DNA through biological nanopores in the laboratory of Professor Daniel Branton. After completing her Ph.D., she joined a start-up company BioScale, Inc. developing infectious disease and protein diagnostics on bioMEMS resonating membrane platform technology. Dr. Sauer-Budge joined Fraunhofer CMI in 2007 to lead their biomedical group. Her research portfolio includes rapid diagnostics (point-of-care, microfluidics, biosensors, assay development), tissue engineering (bio-printing), medical devices (multi-functional surgical tools and wearable monitors), and bench-top instrumentation. Some of her recent projects include design and development integrated lab-on-a-chip molecular diagnostics for pathogen detection from physiological samples, isolation of pathogens from blood for integration with novel surface enhanced Raman spectroscopy that enables strain specificity, novel methods for rapid antibiotic susceptibility detection within minutes, novel surgical tools and coatings for implantable devices, wearable chemotherapy monitors, and handheld drug detection systems. Dr. Sauer-Budge also manages the beta-prototyping core for the NIH Center for Future for Technologies in Cancer Care - a translational research and engineering programs.
Dr. Sauer-Budge is currently Biotechnology Managing Scientist, Exponent, Inc.
|
|
|
